TN2009000303A1 - Iron-hydrocarbon complex compounds - Google Patents

Iron-hydrocarbon complex compounds

Info

Publication number: TN2009000303A1
Authority: TN; Tunisia
Prior art keywords: iron; complex compounds; hydrocarbon complex; complex compound; carbohydrate complex
Prior art date: 2007-01-19

Application number

TNP2009000303A

Other languages

English (en)

Inventor

Stefan Reim

Peter Geisser

Original Assignee

Vifor Int Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-19

Filing date

2009-07-17

Publication date

2010-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38441703&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000303(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-07-17 Application filed by Vifor Int Ag filed Critical Vifor Int Ag

2010-12-31 Publication of TN2009000303A1 publication Critical patent/TN2009000303A1/fr

Links

150000001875 compounds Chemical class 0.000 title abstract 3
239000004215 Carbon black (E152) Substances 0.000 title 1
CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 abstract 1
208000015710 Iron-Deficiency Anemia Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Obesity (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compounds Of Iron (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Carbon And Carbon Compounds (AREA)
Medicinal Preparation (AREA)

TNP2009000303A 2007-01-19 2009-07-17 Iron-hydrocarbon complex compounds TN2009000303A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07100803A EP1947120A1 (fr)	2007-01-19	2007-01-19	Liaisons complexes d'hydrate de carbone de fer
PCT/EP2008/050387 WO2008087135A1 (fr)	2007-01-19	2008-01-15	Composés complexes de fer/glucides

Publications (1)

Publication Number	Publication Date
TN2009000303A1 true TN2009000303A1 (en)	2010-12-31

Family

ID=38441703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000303A TN2009000303A1 (en)	2007-01-19	2009-07-17	Iron-hydrocarbon complex compounds

Country Status (25)

Country	Link
US (1)	US8263564B2 (fr)
EP (2)	EP1947120A1 (fr)
JP (1)	JP5225289B2 (fr)
KR (1)	KR101200992B1 (fr)
CN (1)	CN101589064B (fr)
AR (1)	AR064786A1 (fr)
AU (1)	AU2008206969B2 (fr)
BR (1)	BRPI0807037A2 (fr)
CA (1)	CA2675117C (fr)
CL (1)	CL2008000140A1 (fr)
ES (1)	ES2732290T5 (fr)
GT (1)	GT200900204A (fr)
HK (1)	HK1135417A1 (fr)
IL (1)	IL199726A (fr)
MA (1)	MA31113B1 (fr)
MX (1)	MX2009007695A (fr)
MY (1)	MY148299A (fr)
NZ (1)	NZ578457A (fr)
PE (1)	PE20090187A1 (fr)
RU (1)	RU2423122C2 (fr)
SA (1)	SA08290017B1 (fr)
TN (1)	TN2009000303A1 (fr)
TW (1)	TWI388330B (fr)
WO (1)	WO2008087135A1 (fr)
ZA (1)	ZA200905738B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120214986A1 (en) *	2009-11-04	2012-08-23	Symed Labs Limited	Process for the preparation of iron (iii) carboxymaltose complex
CN101967205B (zh) *	2010-10-12	2013-04-17	滨州学院	一种β-葡聚糖铁复合物及其制备方法
CN106176808A (zh) *	2010-10-19	2016-12-07	长春纳米生技公司	金属离子纳米簇组合物
WO2012104204A1 (fr)	2011-01-31	2012-08-09	Vifor (International) Ag	Composés à base d'un complexe de fer-hydrate de carbone pour la thérapie intraveineuse du paludisme
CN103946019B (zh)	2011-10-13	2016-10-05	维达西姆公司	铁-纤维组合物、其制备和用途
WO2014065890A1 (fr) *	2012-10-25	2014-05-01	Otc Nutrition Llc	Compositions de complément minéral de calcium solide à dissolution rapide et procédé de préparation
RU2641030C2 (ru) *	2012-12-21	2018-01-15	Вифор (Интернациональ) Аг	Комплексные соединения трехвалентного железа для лечения и профилактики симптомов дефицита железа и железодефицитных анемий
CA2901018C (fr) *	2013-03-08	2022-05-03	Vidasym, Inc.	Compositions complexes a constituant ion metallique-fibre fonctionnelle, leur preparation et leurs utilisations
US20180147238A1 (en) *	2015-05-29	2018-05-31	Sun Pharmaceutical Industries Ltd.	Composition of iron sucrose and process for its preparation
US10258647B2 (en)	2015-09-01	2019-04-16	Particle Dynamics International, Llc	Iron-polysaccharide complexes and methods for the preparation thereof
RU2625739C1 (ru) *	2016-09-28	2017-07-18	Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб"	Фармакологическая композиция на основе соединений железа
SMT202300276T1 (it)	2019-02-28	2023-11-13	Renibus Therapeutics Inc	Nuove composizioni a base di ferro e metodi di realizzazione e uso delle stesse
CN112156109A (zh) *	2020-09-29	2021-01-01	神奈纳米医药技术(珠海)有限公司	氢氧化铁-糖络合物的制备方法及其应用
RU2763135C1 (ru) *	2021-04-23	2021-12-27	Виктор Павлович Ремез	Фармакологическая композиция для лечения железодефицитной анемии
US20240408569A1 (en) *	2021-09-10	2024-12-12	The European Atomic Energy Community (Euratom), Represented By The European Commission	Embedded product for the transportation, storage and/or handling of lanthanides or actinides and method of manufacturing
WO2023041957A1 (fr) *	2021-09-16	2023-03-23	Virchow Biotech Private Limited	Procédé efficace pour la synthèse de complexes glucidiques de fer (iii)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617463A1 (de) *	1965-11-20	1971-04-08	Bayer Ag	Verfahren zur Herstellung von injizierbaren kolloidalen Eisenzubereitungen
DE3026868C2 (de) *	1980-07-16	1986-03-13	Laboratorien Hausmann AG, St. Gallen	Verfahren zur Herstellung von Eisen(III)hydroxid-Dextran-Komplexen und sie enthaltende pharmazeutische sterile wäßrige Lösung
CA1319612C (fr)	1987-07-02	1993-06-29	Haile Mehansho	Supplements mineraux fer-calcium a biodisponibilite amelioree
US4786518A (en)	1987-07-02	1988-11-22	The Procter & Gamble Company	Iron mineral supplements
DE3844065A1 (de) †	1988-12-28	1990-07-05	Orgaplan Gmbh	Glycosidische eisen-ii- und eisen-iii-komplexzubereitungen und ihre verwendung
DK172860B1 (da) *	1998-03-25	1999-08-16	Pharmacosmos Holding As	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
US6461651B1 (en) *	2000-09-26	2002-10-08	General Mills, Inc.	Sodium-free iron complex for food fortification
RU2198665C1 (ru) *	2001-12-27	2003-02-20	Общество с ограниченной ответственностью Фирма "А-БИО"	Способ получения железосодержащего лекарственного средства
DE10249552A1 (de) *	2002-10-23	2004-05-13	Vifor (International) Ag	Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7964568B2 (en) *	2003-05-30	2011-06-21	Chromaceutical Advanced Technologies, Inc.	Synthesis of high molecular weight iron-saccharidic complexes
WO2005116046A1 (fr) *	2004-05-24	2005-12-08	Cilag Ag	Procede de production d'un complexe fer-saccharose
WO2006006897A1 (fr)	2004-07-09	2006-01-19	Telefonaktiebolaget Lm Ericsson (Publ)	Procede et dispositif destines a fournir differents services dans un systeme de communication multimedia
CN1739531A (zh) *	2005-09-12	2006-03-01	南京生命能科技开发有限公司	一种治疗缺铁性贫血的蔗糖铁注射液及其制备方法
CN101215338B (zh) *	2007-01-05	2010-09-15	庄茅	异麦芽低聚糖铁及其制备方法
CN101390923A (zh) *	2007-09-21	2009-03-25	韩泳平	一种红景天多糖铁复方制剂的制备及应用

2007
- 2007-01-19 EP EP07100803A patent/EP1947120A1/fr not_active Withdrawn
2008
- 2008-01-04 TW TW097100346A patent/TWI388330B/zh not_active IP Right Cessation
- 2008-01-08 AR ARP080100071A patent/AR064786A1/es not_active Application Discontinuation
- 2008-01-15 ES ES08707897T patent/ES2732290T5/es active Active
- 2008-01-15 KR KR1020097017320A patent/KR101200992B1/ko active Active
- 2008-01-15 MY MYPI20092927A patent/MY148299A/en unknown
- 2008-01-15 NZ NZ578457A patent/NZ578457A/en not_active IP Right Cessation
- 2008-01-15 WO PCT/EP2008/050387 patent/WO2008087135A1/fr active Application Filing
- 2008-01-15 MX MX2009007695A patent/MX2009007695A/es active IP Right Grant
- 2008-01-15 BR BRPI0807037-7A patent/BRPI0807037A2/pt not_active IP Right Cessation
- 2008-01-15 EP EP08707897.8A patent/EP2111416B2/fr active Active
- 2008-01-15 US US12/523,331 patent/US8263564B2/en active Active
- 2008-01-15 CA CA2675117A patent/CA2675117C/fr not_active Expired - Fee Related
- 2008-01-15 RU RU2009131464/05A patent/RU2423122C2/ru active
- 2008-01-15 JP JP2009545912A patent/JP5225289B2/ja active Active
- 2008-01-15 CN CN200880002590.4A patent/CN101589064B/zh not_active Expired - Fee Related
- 2008-01-15 AU AU2008206969A patent/AU2008206969B2/en not_active Ceased
- 2008-01-16 SA SA08290017A patent/SA08290017B1/ar unknown
- 2008-01-17 CL CL200800140A patent/CL2008000140A1/es unknown
- 2008-01-17 PE PE2008000154A patent/PE20090187A1/es not_active Application Discontinuation
2009
- 2009-07-07 IL IL199726A patent/IL199726A/en not_active IP Right Cessation
- 2009-07-17 TN TNP2009000303A patent/TN2009000303A1/fr unknown
- 2009-07-17 GT GT200900204A patent/GT200900204A/es unknown
- 2009-07-27 MA MA32121A patent/MA31113B1/fr unknown
- 2009-08-18 ZA ZA200905738A patent/ZA200905738B/xx unknown
2010
- 2010-02-22 HK HK10101847.1A patent/HK1135417A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL199726A0 (en)	2010-04-15
BRPI0807037A2 (pt)	2014-04-22
AR064786A1 (es)	2009-04-22
HK1135417A1 (en)	2010-06-04
CL2008000140A1 (es)	2008-05-16
SA08290017B1 (ar)	2011-09-13
JP5225289B2 (ja)	2013-07-03
ES2732290T3 (es)	2019-11-21
EP2111416A1 (fr)	2009-10-28
IL199726A (en)	2014-05-28
CA2675117C (fr)	2014-03-25
CA2675117A1 (fr)	2008-07-24
RU2009131464A (ru)	2011-03-10
CN101589064B (zh)	2014-01-29
EP2111416B1 (fr)	2019-05-15
US20100035830A1 (en)	2010-02-11
PE20090187A1 (es)	2009-03-15
WO2008087135A1 (fr)	2008-07-24
AU2008206969A1 (en)	2008-07-24
EP1947120A1 (fr)	2008-07-23
MX2009007695A (es)	2009-07-29
KR101200992B1 (ko)	2012-11-13
JP2010516828A (ja)	2010-05-20
MY148299A (en)	2013-03-29
ZA200905738B (en)	2010-05-26
AU2008206969B2 (en)	2012-12-06
EP2111416B2 (fr)	2022-03-30
GT200900204A (es)	2010-07-22
TW200835511A (en)	2008-09-01
CN101589064A (zh)	2009-11-25
KR20090102861A (ko)	2009-09-30
ES2732290T5 (es)	2022-06-07
TWI388330B (zh)	2013-03-11
US8263564B2 (en)	2012-09-11
NZ578457A (en)	2011-08-26
RU2423122C2 (ru)	2011-07-10
MA31113B1 (fr)	2010-01-04

Publication	Publication Date	Title
TN2009000303A1 (en)	2010-12-31	Iron-hydrocarbon complex compounds
TW200716606A (en)	2007-05-01	Chemical compounds
HK1113352A1 (en)	2008-10-03	Chemical compounds
TW200800963A (en)	2008-01-01	Chemical compounds
HK1114375A1 (en)	2008-10-31	Chemical compounds
MX2009007075A (es)	2009-12-14	Metodos de uso para analogos de ciclopamina.
TW200626068A (en)	2006-08-01	Active compounds for seed treatment
MX2009006307A (es)	2009-06-23	Adsorbente de fosfato a base de hierro (iii)-carbohidrato.
MX2007014172A (es)	2008-04-02	Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
MY163852A (en)	2017-10-31	Amidophenoxyindazoles useful as inhibitors of c-met.
HK1112856A1 (en)	2008-09-19	Diarylhydantoin compound
TW200640924A (en)	2006-12-01	VEGF-R2 inhibitors and methods
MY148634A (en)	2013-05-15	Pyridazinone derivatives
WO2007085895A3 (fr)	2008-04-17	Inhibiteurs fap
MY153915A (en)	2015-04-15	Organic compounds
UA102251C2 (ru)	2013-06-25	Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера
MX2008007808A (es)	2008-09-15	Analogos de rifamicina y usos de ellos.
GB2466912A (en)	2010-07-14	Compositions and methods for treating lysosomal disorders
IL204552A0 (en)	2010-11-30	Mixed metal compounds for treatment of hyperphos phataemia
MX2009005649A (es)	2009-06-08	Tratamiento para mieloma multiple.
MX2009008660A (es)	2009-10-13	Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
TW200728310A (en)	2007-08-01	Process for the preparation of ferri-succinylcasein
MX2010008226A (es)	2010-10-25	Derivados de difluorobifenilamida para el tratamiento de hipertension ocular.
MX2010005809A (es)	2010-06-09	Proceso de dehidrohalogenacion para la preparacion de intermediarios utiles en el suministro de compuestos 6,6-dimetil-3-azabiciclo-[3,1,0]-hexano.
WO2008053334A3 (fr)	2008-07-03	Procédé amélioré de préparation de rosuvastatine calcique